Filing Flows › Iradimed (IRMD) › Free cash flow
Iradimed (IRMD) free cash flow by quarter
Iradimed's free cash flow was $6.8M in Q3 2026 (third quarter 2026), +18% from Q2 2026. Over the last 7 quarters it ranged from $375K (Q1 2025) to $7.8M (Q1 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $6.8M | +18% | +19% |
| Q2 2026 | $5.8M | -26% | +17% |
| Q1 2026 | $7.8M | +42% | 21× |
| Q4 2025 | $5.5M | -4% | — |
| Q3 2025 | $5.7M | +16% | — |
| Q2 2025 | $4.9M | 13× | — |
| Q1 2025 | $375K | — | — |
Q3 2026 at a glance
Iradimed, Q3 2026: revenue $24.2M (+14% year over year), operating margin 33.6%, net earnings $6.5M, operating cash flow $7.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Iradimed's free cash flow?
Iradimed's free cash flow was $6.8M in Q3 2026 (third quarter 2026), +18% from Q2 2026.
How has Iradimed's free cash flow changed?
Over the last 7 quarters it ranged from $375K (Q1 2025) to $7.8M (Q1 2026).